CVR Medical Corp.

Equities

CVM.H

CA1266321084

Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 12:42:33 06/05/2022 am IST			5-day change	1st Jan Change
0.015 ^CAD	-25.00%		-.--%	-.--%

2022	CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	CVR Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

CVR Medical Corp. Appoints Michael Rhodes as Chief Executive Officer

January 19, 2021 at 07:09 pm IST

CVR Medical Corp. announced that the appointment of Michael Rhodes as Chief Executive Officer. Michael is a proven senior executive and has held several leadership positions at Fortune 100 and Fortune 500 Companies including Chief Quality Officer at Motorola Solutions Inc. based in Chicago and Global Head of Quality for Technology at HSBC in London.

Latest news about CVR Medical Corp.

CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/22/01	CI
CVR Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	07/22/07	CI
CVR Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/22/20	CI
CVR Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	15/22/15	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	14/22/14	CI
CVR Medical Corp. announced that it has received CAD 0.06016 million in funding	06/22/06	CI
CVR Medical Corp. announced that it expects to receive CAD 0.1 million in funding	12/22/12	CI
CVR Medical Corp. announced that it expects to receive CAD 0.1875 million in funding	18/22/18	CI
CVR Medical Corp. announced that it has received CAD 0.1155 million in funding	23/21/23	CI
CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29/21/29	CI
CVR Medical Corp. announced that it expects to receive CAD 0.15 million in funding	08/21/08	CI
CVR Medical Corp. Announces the Appointment of Darren Day as Chief Executive Officer	02/21/02	CI
Cvr Medical Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	31/21/31	CI
CVR Medical Corp. Announces Earnings Results for the First Quarter Ended March 31, 2021	01/21/01	CI
CVR Medical Corp. Announces Resignation of Harvey Mckenzie as Financial Advisor and Nominee to the Board of Directors	29/21/29	CI
CVR Medical Corp. Announces Resignation of Michael Rhodes as CEO	29/21/29	CI
Cvr Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	30/21/30	CI
CVR Medical Corp. Appoints Michael Rhodes as Chief Executive Officer	19/21/19	CI
Cvr Medical Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	01/20/01	CI
CVR Medical Corp. Announces Executive Changes	29/20/29	CI
CVR Medical Corp. Announces Executive Changes	29/20/29	CI
Cvr Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	12/20/12	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	11/20/11	CI
CVR Medical Corp. Announces Resignation of Dallas Hack as Interim CEO, CFO and as Member of the Board of Directors	09/20/09	CI

Chart CVR Medical Corp.

Duration

Period

More charts

Company Profile

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Companyâs Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
CVR MEDICAL CORP.	-.--%	1.45M
EXACT SCIENCES CORPORATION	-39.38%	8.28B
GUARDANT HEALTH, INC.	+9.28%	3.62B
IOVANCE BIOTHERAPEUTICS, INC.	-1.48%	2.24B
BGI GENOMICS CO., LTD.	-22.85%	1.94B
VERACYTE, INC.	-18.07%	1.72B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+10.53%	962M
CAREDX, INC	+17.17%	734M
SEEGENE, INC.	-9.17%	690M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-33.88%	477M

Bio Diagnostics & Testing